extended for analogs) GLP-3: Not well characterized Side Effects GLP-1: Nausea (common initially) Vomiting Diarrhea or constipation Reduced appetite Potential pancreatitis (rare) GLP-2: Generally well-tolerated Injection site reactions Abdominal pain or discomfort Nausea (less common than GLP-1) Fluid retention GLP-3: Unknown (no clinical use) Availability GLP-1: Widely available through prescription medications (semaglutide, liraglutide, etc.) and research peptides GLP-2: Available as teduglutide (Gattex/Revestive) by prescription
According to MenuData, restaurants and bars are rapidly evolving to meet the needs of GLP-1 users, whose reduced appetites and shifting consumption habits are redefining the dining experience
TMAO can upregulate scavenger receptors, such as cluster of differentiation 36 (CD36) and scavenger receptor class A type 1 (SR-A1), and promote the formation of foam cells, leading to development and progression of atherosclerosis (63)
The 6-session structure provides long-lasting brightness while maintaining skin health and safety
Feel the Difference: Use 1-2 times daily or as prescribed, and experience results in as little as an hour
Dermatol Surg 2022;48:12104